ASIC Corporations (Margin Lending Relief for Exchange-Traded Instalment Warrants) Instrument 2021/194

Overview

The ASIC Corporations (Margin Lending Relief for Exchange-Traded Instalment Warrants) Instrument 2021/194 was enacted to address a specific gap in the regulation of margin lending facilities associated with exchange-traded instalment warrants. This legislative instrument was made under the authority of subsection 761EA(9) of the Corporations Act 2001 and seeks to clarify the scope of what constitutes a margin lending facility in the context of financial products such as instalment warrants. The policy objective is to ensure that certain financial products do not inadvertently fall under the definition of a margin lending facility, thereby affecting the regulatory approach towards them. The instrument exempts specific classes of financial products from being classified as margin lending facilities, provided they meet certain criteria such as being admitted to quotation on a declared financial market and being issued by a financial services licensee. This legislative instrument is an example of how the Australian Securities and Investments Commission (ASIC) aims to provide clarity and ensure the appropriate regulatory framework is applied to financial products. The instrument is set to be repealed on 1 April 2031, reflecting its temporary nature and the potential for future amendments based on evolving market conditions and regulatory needs.

Scope and Application

The ASIC Corporations (Margin Lending Relief for Exchange-Traded Instalment Warrants) Instrument 2021/194 is a legislative instrument made under the Corporations Act 2001. It provides relief for certain margin lending facilities associated with exchange-traded instalment warrants. The instrument applies to instalment warrants that are admitted to quotation on a declared financial market, are issued by a financial services licensee, and are considered standard margin lending facilities. The key purpose of this instrument is to declare that such facilities are not to be classified as margin lending facilities, while still acknowledging that these products remain financial products under the Corporations Act. The instrument's application is specific to the financial services sector and the issuance of exchange-traded instalment warrants. It operates nationally as it is an instrument made under Commonwealth legislation. The instrument has a set expiry date of 1 April 2031, after which it will be repealed, unless further extended or amended by another legislative action. The instrument's provisions may also be subject to modification by other laws, although such modifications do not alter the text of the instrument itself. Any uncommenced amendments or repealing provisions are detailed in the endnotes of the compiled law.

Key Provisions

The ASIC Corporations (Margin Lending Relief for Exchange-Traded Instalment Warrants) Instrument 2021/194 (the Instrument) is made under subsection 761EA(9) of the Corporations Act 2001 (the Act). The Instrument aims to provide relief for margin lending facilities associated with exchange-traded instalment warrants (Section 3). Specifically, Section 5 declares that certain instalment warrants that meet specified criteria are not considered margin lending facilities. This includes warrants that are in a class of financial products admitted to quotation on a declared financial market, issued by a financial services licensee, and are standard margin lending facilities. Despite this declaration, these warrants remain classified as financial products (Section 5 Note). The Instrument imposes obligations on financial services licensees and Australian Securities and Investments Commission (ASIC) in relation to the classification of margin lending facilities for exchange-traded instalment warrants. Financial services licensees must ensure that their issuance of such warrants complies with the criteria set out in Section 5 of the Instrument. ASIC, on the other hand, is responsible for overseeing and enforcing the compliance of these financial products with the declared terms and conditions. The Instrument specifies that the declaration does not alter the financial product status of these warrants, clarifying that they remain subject to the broader regulatory framework under the Act (Section 5 Note). The Instrument includes provisions for penalties and consequences in the event of non-compliance with its terms. While the Instrument does not explicitly detail specific penalties, non-compliance with the Act and its regulations, including this Instrument, can lead to significant civil and criminal penalties. Financial services licensees found in breach of the Act could face fines up to the statutory maximum of $2,100,000 for corporations and $420,000 for individuals, in addition to potential imprisonment terms. ASIC also has the authority to seek court orders for redress, including compensation orders, and to pursue further enforcement actions against non-compliant entities. The Instrument is set to be repealed on 1 April 2031, as outlined in Section 6. Until that date, the terms and conditions set forth in the Instrument will govern the classification and regulation of margin lending facilities for exchange-traded instalment warrants. The endnotes provide detailed information on the amendment history and legislative changes affecting the Instrument, ensuring transparency and clarity for practitioners and stakeholders.